Conservation of metacyclic variant surface glycoprotein expression sites among different trypanosome isolates

We identified in a Trypanosoma brucei brucei strain (AnTat 1) an expression site for a metacyclic variant surface glycoprotein (MVSG) gene (MVSG) that was previously characterized in a T. b. rhodesiense strain (WRATat 1.1). The 3.4 kb sequences of the two expression sites are 99.6% identical, with no differences in the sequence of the 1.5 kb MVSG. Two other MVSGs in the WRATat 1.1 genome are not present in the AnTat 1 genome. In addition, five other T. b. brucei and T. b. rhodesiense strains, isolated in the same geographic region as the two former strains, do not contain any of these three MVSGs. Two of these five strains, however, appear to possess a very similar MVSG expression site, but with different MVSGs in it. Thus, the presence of the same MVSG in the same expression site in two different isolates is unusual and may be the result of genetic exchange in the field between T. b. brucei and T. b. rhodesiense isolates. Analysis of other African trypanosome strains for the presence of the three WRATat 1.1 MVSG expression sites demonstrated that the expression sites' promoter sequences are much more likely to be present than are specific MVSGs, suggesting that loss of MVSGs is the result of replacement by other VSGs. The promoter region of the MVSG expression site active in the WRATat 1.1 MVAT7 variant was found to be highly conserved among T. b. brucei, T. b. rhodesiense and T. b. gambiense group 2 isolates, whereas it does not occur in the T. b. gambiense group 1 isolates tested. A phylogenetic analysis of this promoter region sequence shows that the T. b. gambiense group 2 isolates form a monophyletic clade well separated from the T. b. brucei/T. b. rhodesiense isolates. Thus, whilst the T. b. brucei, T. b. rhodesiense and T. b. gambiense group 2 isolates are closely related but heterogenous, molecular tools may be developed to distinguish T. b. gambiense group 2 isolates from the others.     

Conservation of structure detected in two trypanosome surface glycoproteins by amino acid sequence alignment

The predominant molecule exposed to antibody on the surface of Trypanosoma brucei is a glycoprotein of about 60 000 molecular weight which varies in amino acid sequence. The complete sequences of two such variable surface glycoproteins (VSGs) from randomly isolated, different antigenic types of trypanosomes were compared by amino acid sequence alignment. Homologous sequences were found distributed over various regions of the VSGs. Particularly good homology was observed between residues 16-34, 91-115, 177-194 and 254-345 from the N-terminus, in addition to the known conserved region close to the C-terminus. Homology was also demonstrated in the corresponding regions of the cDNA sequences by matrix analysis.     

Purification and characterisation of membrane-form variant surface glycoproteins of Trypanosoma brucei

Membrane-form variant surface glycoprotein of Trypanosoma brucei can be prepared in the presence of para-chloromercuriphenylsulphonic acid. The membrane-bound enzyme that usually cleaves a lipid from this glycoprotein, thus producing the soluble variant surface glycoprotein, is inhibited by a range of sulphydryl reagents. The effect of such inhibitors, both on cell lysates and on semi-purified enzyme, reveals that the enzyme may have a sulphydryl at or near its active site. Fatty acid analysis and isoelectric point measurements of membrane form and soluble form are presented.     

Isolation and cell-free synthesis of variant surface glycoproteins from Trypanosoma congolense

Two Trypanosoma congolense stocks, 1/148 FLY and TREU 921, were cloned in A/J strain mice immunosuppressed with cyclophosphamide. The cloned populations, AmNat 1.1 and AmNat 3.1, each characterized by a different variant antigen type, were checked for homogeneity by the indirect fluorescent antibody test using 6-day antisera developed in rabbits. The variant surface glycoproteins (VSGs) from both AmNat clones were purified to homogeneity. Electrophoresis on sodium dodecyl sulfate (SDS)-polyacrylamide gradient gels revealed that the apparent Mr values of the two VSGs were 51 700 (AmNat 1.1) and 49 900 (AmNat 3.1). Monospecific antisera prepared in rabbits to each VSG were used to confirm the homogeneity of the clones by the indirect fluorescent antibody test. The VSGs were susceptible to endoglycosidase H digestion, indicating the presence of high-mannose type oligosaccharides in these glycoproteins. The apparent Mr values of the endoglycosidase H-digested VSGs were 48 800 and 46 900 for AmNat 1.1 and 3.1, respectively. Poly(A+)-enriched RNA isolated from each clone was assayed for template activity using a mRNA-dependent rabbit reticulocyte lysate for in vitro protein synthesis. Radioactively labeled polypeptides were initially characterized by SDS-polyacrylamide gradient gel electrophoresis and visualized by fluorography. VSG-specific translation products were immunoprecipitated with IgGs isolated from the homologous monospecific antisera and analyzed on SDS-polyacrylamide gradient gels. The apparent Mr values for the AmNat 1.1 and 3.1 precursor VSGs synthesized in vitro were 39 000 and 43 000, respectively.     

Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts.

The variant surface glycoproteins (VSGs) of African trypanosomes form a dense surface coat on the bloodstream parasites. VSGs are immunodominant antigens that stimulate a rapid antibody response in trypanosome-infected individuals. In the present study, we examined VSG-specific antibodies present not only in sera from infected individuals but also in sera from individuals that had never been exposed to trypanosomes. Native antibodies against different VSGs were detected in sera from uninfected mice, bovines, and humans; the antibodies were revealed to be exclusively directed against variable determinants of the antigens. Further experimentation demonstrated that such native antibodies immunoreact with cellular components of mice and thus are most likely produced by the self-reactive B-cell compartment of the murine immune system.     

T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions

Variable subregions within the variant surface glycoprotein (VSG) coat displayed by African trypanosomes are predicted sites for T- and B-cell recognition. Hypervariable subregion 1 (HV-1) is localized to an internal amphipathic alpha helix in VSG monomers and may have evolved due to selective pressure by host T-cell responses to epitopes within this subregion. The prediction of T-cell receptor-reactive sites and major histocompatibility complex class II binding motifs within the HV-1 subregion, coupled with the conservation of amino acid residues in other regions of the molecule sufficient to maintain secondary and tertiary VSG structure, prompted us to test the hypothesis that Th cells may preferentially recognize HV-1 subregion peptides. Thus, we examined the fine specificity of VSG-specific T-cell lines, T-cell hybridomas, and Th cells activated during infection. Our results demonstrate that T-cell epitopes are distributed throughout the N-terminal domain of VSG but are not clustered exclusively within HV-1 or other hypervariable subregions. In contrast, T-cell-reactive sites were not detected within the relatively conserved C-terminal domain of VSG. Overall, this study is the first to dissect the fine specificity of T-cell responses to the trypanosome VSG and suggests that evolution of a conserved HV-1 region may be unrelated to selective pressures exerted by host T-cell responses. This study also demonstrates that T cells do not recognize the relatively invariant C-terminal region of the VSG molecule during infection, suggesting that it could serve as a potential subunit vaccine to provide variant cross-specific immunity for African trypanosomiasis.     

The inositol-1,2-cyclic phosphate moiety of the cross-reacting determinant,carbohydrate chains,and proteinaceous components are all responsible for the cross-reactivity of trypanosome variant surface glycoproteins

Salivarian trypanosomes evade the host immune system by continually swapping their protective variant surface glycoprotein (VSG) coat. Given that VSGs from various trypanosome stocks exhibited cross-reactivity (Camargo et al., Vet. Parasitol. 207, 17–33, 2015), we analyzed here which components are the antigenic determinants for this cross-reaction. Soluble forms of VSGs were purified from four Venezuelan animal trypanosome isolates: TeAp-N/D1, TeAp-ElFrio01, TeAp-Mantecal01, and TeGu-Terecay323. By using the VSG soluble form from TeAp-N/D1, we found that neither the inositol-1,2-cyclic phosphate moiety of the cross-reacting determinant nor the carbohydrate chains were exclusively responsible for its cross-reactivity. Then, all four purified glycoproteins were digested with papain and the resulting peptides were separated by high-performance liquid chromatography. Dot blot evaluation of the fractions using sera from trypanosome-infected animals yielded peptides that possessed cross-reaction activity, demonstrating for the first time that proteinaceous epitopes are also responsible for the cross-reactivity of trypanosome VSGs.     

Rapid preparative scale purification of myristylated variant surface glycoproteins from African trypanosomes

A rapid method for the preparative-scale purification of variant surface glycoproteins (VSG) from African trypanosomes has been developed to investigate the recently described myristylated form of this molecule. This high-performance liquid chromatography (HPLC) procedure gives high yields and can be achieved in as little as 1 h from the preparation of a cell lysate in 0.1% trifluoroacetic acid (TFA). Solubilization of myristylated VSG in 0.1% TFA was shown to be much more effective than in neutral or zwitterionic detergents. Surface iodination of bloodstream trypanosomes and subsequent lysis in TFA showed that no proteolytic degradation of VSG occurred during solubilization and purification. Biosynthetic labelling of trypanosomes with [3H]myristic acid and purification of VSG by the described method, demonstrated that the VSG possessed covalently linked fatty acid and can therefore be defined as the membrane form of VSG. Evidence was provided that the myristic acid was covalently associated with the C-terminal portion of the VSG via a hydroxyester bond. Solubilization of the myristylated VSG by 0.1% TFA could be interpreted to indicate that the fatty acid was not embedded in the trypanosome membrane.     

Structural features of antigenic determinants on variant surface glycoproteins from Trypanosoma brucei

The immunochemical structure of two variant surface glycoproteins (VSGs) from Trypanosoma brucei has been studied using monoclonal and polyclonal antibodies. These two VSGs, WaTat 1.1 and WaTat 1.12 have been shown to possess cross-reactive surface-exposed antigenic determinants [Barbet et al., Nature 300, 53-57 (1982)] and similar N-terminal amino acid sequences [Olafson et al., Molec. Biochem. Parasit. 12, 287-298 (1984)]. Monoclonal and polyclonal antibodies were raised against the soluble forms of the two VSGs and against their reduced, alkylated and cyanogen bromide (CNBr) cleaved forms. None of the monoclonal antibodies which bound to the surface of living trypanosomes bound to CNBr fragments of the VSGs nor to denatured VSGs. Polyclonal antibodies raised against denatured and cleaved VSG did not bind to the surface of the living trypanosomes. These results suggest that the variable surface exposed antigenic determinants of VSG are topographically assembled structures. It was also shown that the conserved amino terminal peptides of WaTat 1.1 and WaTat 1.12 do not contain antigenic determinants.     

Isotypic surface glycoproteins of trypanosomes.

We have identified cloned populations of trypanosomes, derived from different original field isolates and species, which appeared to possess similar variable surface-antigen types when assayed by immune lysis and immunofluorescence tests. Variable surface glycoproteins (VSGs) were isolated from these 'isotypic' trypanosomes. Isolated VSGs had identical apparent mol. wt of 60,000 but different isoelectric points. Radioimmunoassay, using 125I-labelled VSGs and rabbit anti-VSG sera, showed that isotypic VSGs contained not only the cross-reacting determinants found in all other VSGs (Barbet & McGuire, 1978) but also other cross-reacting determinants shared between isotypes. Peptide mapping revealed extensive amino-acid sequence homology between isotype VSGs.     

The genes coding for the surface glycoproteins of influenza A viruses contain a small conserved and a large variable region.

The variable genes of influenza A viruses coding for hemagglutinin and neuraminidase consist of a relatively small highly conserved region, which is presumably involved in the functional integrity of the gene products, and a relatively large highly variable region, presumably involved in the immunological properties. This is demonstrated by melting profiles of homologous and heterologous RNA hybrid molecules. The results are discussed as a possible mechanism how serologically different influenza strains evolve by mutation in the variable part and selection by the immune system of the host.     

Fifty years of structural glycoproteins

During decades preceding and following the last war, a favourite subject of biochemists was to study glycoproteins. One class of these substances, found in connective tissues were characterised as polysaccharides, most of them found to be linked to proteins, designated later as glycosaminoglycans and proteoglycans. Another family of glycoconjugates represented epithelial mucins as found in the gastro-intestinal and respiratory tracts and conduits. A third family of glycoconjugates is represented by circulating glycoproteins isolated from the blood plasma, mostly studied by medical biochemists in relation to pathological conditions comprising those increasing during the inflammatory reaction: acute phase glycoproteins. Their study suggested that they might be derived from connective tissues. Although inflammatory glycoproteins derive mostly from the liver, the possibility of connective tissue origin of glycoproteins remained open. Using cornea, an avascular tissue, we could show that connective tissues also synthesize glycoproteins. We proposed to designate them "structural glycoproteins" (SGP-s) to distinguish them from circulating, blood-born glycoproteins coming from the liver. They play locally "structural" roles in connective tissues where they are synthesized. Soon after fibronectin was identified and shown to mediate cell-matrix interactions. A large family of glycoproteins were then isolated from a variety of sources, cells, tissues others than liver, confirming our original hypothesis. The first experiments on these glycoproteins were published from 1961/1962 giving the opportunity to recapitulate this biochemical adventure 50 years later, together with the celebration of the foundation of the first connective tissue society in Europe, as described in the first article in this issue.     

Glycosyl-sn-1,2-dimyristylphosphatidylinositol is the membrane anchor for Trypanosoma equiperdum and T. (Nannomonas) congolense variant surface glycoproteins

We have analysed the structures of the Trypanosoma (Nannomonas) congolense and T. equiperdum variant surface glycoprotein (VSG) membrane anchors. Myristic acid uptake, phospholipase treatment, and nitrous acid deamination showed that, for each species, the anchor is glycosyl-sn-1,2-dimyristylphosphatidylinositol, as has been previously described for T. brucei. Osmotic lysis of these trypanosomes resulted in the release of soluble VSG, lacking fatty acid. In both species and in T. evansi, an endogenous phospholipase C, which cleaved diacylglycerol from membrane form VSG, was identified.     

Characterisation of the cross-reacting carbohydrate groups on two variant surface glycoproteins of Trypanosoma brucei

The nature of the cross-reacting groups on two variant surface glycoproteins of Trypanosoma brucei has been investigated after isolation of glycopeptides produced by extensive proteolytic digestion of the proteins. One variant yielded two glycopeptides after pronase digestion, one of which was the glycosylated C-terminal aspartic acid. In a second variant there are two carbohydrate groups close to the C-terminus. Considerable heterogeneity in the size of the sugar attached to an asparagine residue was detected whereas the C-terminal serine was glycosylated but showed no size heterogeneity. For both variants it was shown that the C-terminal glycosylated amino acid (either aspartic acid or serine) was responsible for the immunological cross-reaction between distinct variant glycoproteins. The stability of the cross-reacting determinant was also investigated.     

Immunological properties of murine thymus-dependent lymphocyte surface glycoproteins.

The immunological properties of two murine thymus-dependent (T) lymphocyte surface glycoproteins, T200 and T25, were investigated. T200 is a lymphocyte-specific antigen with a high degree of species specificity. It shares antigenic determinants with molecules present on thymus-independent (B) lymphocytes. T25 has antigenic determinants which cross-react with antigens on mouse brain, rat thymocytes and rat brain. An antiserum against a purified rat brain glycoprotein which carries Thy-1.1 reacts with T25. Absorption of this antiserum with BALB/c thymocytes or brain homogenate produces a Thy-1.1 specific serum which reacts with T25 from AKR/J thymocytes but not with T25 from AKR/Cum thymocytes. These results confirm that T25 is the molecule on the surface of mouse T cells which carries the Thy-1 antigen. T25 also carries antigenic determinants, recognized by anti-thymocyte serum (ATS), which were found on secondary mouse embryo fibroblasts and untransformed fibroblast cell lines but which were not detected on fibroblast cell lines transformed with murine sarcoma virus (MSV) or with Simian virus 40 (SV40).     

Biosynthesis of Trypanosoma brucei variant surface glycoproteins — Analysis of carbohydrate heterogeneity and timing of post-translational modifications

The variant surface glycoproteins from two cloned populations of Trypanosoma brucei brucei which were known to migrate as multiple bands on SDS gels have been studied. The heterogeneity present was located in those oligosaccharide side chains the addition of which is tunicamycin-sensitive. The time required for the trypanosome to synthesize and express a variant surface glycoprotein molecule in vitro was found, from pulse-chase and limited trypsinisation experiments, to be approximately 40 min. In the light of these data, pulse-chase experiments on the two antigens known to have heterogeneity in their oligosaccharide side chains demonstrated that the heterogeneity probably arose by two different mechanisms. Pulse-chase experiments on three different clones of trypanosomes have also been used to investigate the timing of cleavage of the carboxyl-terminal extension, known to be encoded on variant surface glycoprotein mRNA. Similar pulse-chase experiments followed by immunoprecipitation using affinity purified antiserum have been used to investigate the addition of the cross-reacting determinant. The timing of both these events has been discussed in relation to the time necessary for the synthesis and expression of the variant surface glycoprotein on the surface of the trypanosome.     

Organization of two invariant surface glycoproteins in the surface coat of Trypanosoma brucei.

The surface coat of Trypanosoma brucei, formed by about 10(7) molecules of the membrane-form variant surface glycoprotein (mfVSG) per cell, is generally considered to constitute a barrier against the access of antibodies directed to invariant surface proteins. The recent characterization of two invariant surface glycoproteins (ISGs) with apparent molecular masses of 65 and 75 kDa (ISG65 and ISG75; 70,000 and 50,000 molecules per cell, respectively), which are both predicted to be composed of large extracellular domains, single transmembrane alpha-helices, and small intracellular domains, enabled a critical test of this hypothesis. Although ISG65 is distributed over the entire surface of the parasites, it is not accessible to antibodies or to the proteinase trypsin in live cells provided the mfVSG is also proteinase resistant. ISG75 is similarly distributed; its accessibility to antibodies depends on the expressed mfVSG, and it is sensitive to trypsin in a variant clone in which the mfVSG is proteinase resistant. Vaccination experiments using recombinant proteins to a mixture of the native ISGs were unsuccessful. ISG65 but not ISG75 elicited an antibody response in chronically infected mice. The results strengthen the view of the protective properties of the variant surface glycoprotein coat by steric hindrance and suggest that additional factors such as low abundance or low immunogenicity of invariant surface proteins may prevent a control of the disease by the humoral immune response.     

Isolation and structural analysis of influenza C virion glycoproteins

Influenza C virions possess a single glycoprotein that is cleaved into two disulfide-linked subunits, gp65 and gp30. When analyzed under nonreducing conditions, the uncleaved (gpI) and cleaved (gpI) glycoproteins differ significantly in apparent molecular weight; however, we observed no difference in their tryptic peptide patterns. We have isolated the glycoproteins by selective solubilization with Triton X-100 or octylglucoside; only preparations obtained with the latter detergent showed hemagglutinating activity. In purified glycoprotein samples, gp65 was routinely observed as a doublet on SDS-polyacrylamide gels. Analysis of tryptic peptides by ion-exchange chromatography demonstrated that the two gp65 bands have indistinguishable polypeptide backbones; they appear to differ, however, in carbohydrate content. The uncleaved glycoprotein as well as gp65 were resistant to Edman degradation indicating the presence of blocked amino termini, whereas gp30 was observed to have the N-terminal tripeptide sequence NH₂-Ile-Phe-Gly. This sequence is homologous to a sequence at the N termini of influenza A and B HA₂ glycoproteins, except for the presence of an additional terminal glycine residue in these viruses. The influenza C glycoproteins form a regular hexagonal lattice on the viral envelope. This arrangement is sometimes maintained in disrupted virus preparations and in glycoprotein subunits released from the envelope by limited proteolysis, indicating that direct interactions between the glycoprotein molecules are responsible, at least in part, for the observed arrangement. Observations of clustered surface projections on plasma membranes of infected cells, and of released virus particles apparently devoid of internal nucleoproteins, are consistent with the suggestion that lateral interactions between the influenza C glycoproteins may be important in virus assembly.     

Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant

Cloned lines of the methylcholanthrene-induced DBA/2 T lymphoma Eb and its highly metastatic variant line ESb were analyzed for differences in the expression of serologically detectable cell surface differentiation markers. Flow cytofluorographic analysis of cells stained with fluorescein isothiocyanate-conjugated monoclonal rate anti-mouse Thy-1, Lyt-1, Lyt-2 and complement-dependent cytotoxicity with mouse alloantisera against Lyt-3.2 and Ly-6.2 revealed, for the parental low metastasizing line, Eb, a phenotype of Thy-1+, Lyt-1-, Lyt-2+, Lyt-3+, Ly-6+, whereas the highly metastasizing variant line typed as Thy-1-, Lyt-1+, Lyt-2-, Lyt-3-, Ly-6-. Analysis of galactose oxidase/NaB3H4-labeled glycoproteins from Eb and ESb clones by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate showed further phenotypic differences. Selective binding of radiolabeled glycoproteins to Helix pomatia or Vicia villosa-Sepharose, respectively, allowed the identification of T130 to be expressed on Eb cells and T145 to be expressed on some ESb clones. The latter antigen is expressed on murine cytotoxic T lymphocytes. Immune precipitation analysis revealed that Eb and ESb bear different molecular forms of the T200 antigen. Comparisons of iodinated surface proteins derived from tumor cells either treated or untreated with tunicamycin indicated that many of the differences in membrane proteins between Eb and ESb cells could be attributed to differences in glycosylation. Our results, derived from a defined tumor system of lymphoid origin, show that the progression from a low to a high malignant tumor line can be associated with changes in the expression of various defined cell surface differentiation antigens. The question of a possible relationship between tumor progression and cell differentiation or dedifferentiation is discussed.